Estimated Placental Volume and Gestational AgeFunding This study was funded by Reproductive and Placental Research Unit, Yale University School of Medicine.
10 April 2017
10 November 2017
27 December 2017 (eFirst)
Objective The objective of this study was to validate estimated placental volume (EPV) across a range of gestational ages (GAs).
Study Design Three hundred sixty-six patients from 2009 to 2011 received ultrasound scans between 11 + 0 and 38 + 6 weeks GA to assess EPV. An EPV versus GA best fit curve was generated and compared with published normative curves of EPV versus GA in a different population. A subanalysis was performed to explore the relationship between EPV and birth weight (BW).
Results Analysis of EPV versus GA revealed a parabolic curve with the following best fit equation: EPV = (0.372 GA − 0.00364 GA2)3. EPV was weakly correlated with BW, and patients with an EPV in the bottom 50th percentile had 2.42 times the odds of having a newborn with a BW in the bottom 50th percentile (95% confidence interval: 1.27–4.68). Microscopic evaluation of two placentas corresponding to the smallest EPV outliers revealed significant placental pathology.
Conclusion Placental volume increases throughout gestation and follows a predictable parabolic curve, in agreement with the existing literature. Further validation is required, but EPV may have the potential for clinical utility as a screening tool in a variety of settings.
- 1 Thame M, Osmond C, Wilks R, Bennett FI, Forrester TE. Second-trimester placental volume and infant size at birth. Obstet Gynecol 2001; 98 (02) 279-283
- 2 Arleo EK, Troiano RN, da Silva R, Greenbaum D, Kliman HJ. Utilizing two-dimensional ultrasound to develop normative curves for estimated placental volume. Am J Perinatol 2014; 31 (08) 683-688
- 3 Hafner E, Metzenbauer M, Höfinger D. , et al. Comparison between three-dimensional placental volume at 12 weeks and uterine artery impedance/notching at 22 weeks in screening for pregnancy-induced hypertension, pre-eclampsia and fetal growth restriction in a low-risk population. Ultrasound Obstet Gynecol 2006; 27 (06) 652-657
- 4 Harkness UF, Mari G. Diagnosis and management of intrauterine growth restriction. Clin Perinatol 2004; 31 (04) 743-764
- 5 Gilbert WM, Danielsen B. Pregnancy outcomes associated with intrauterine growth restriction. Am J Obstet Gynecol 2003; 188 (06) 1596-1599 , discussion 1599–1601
- 6 Metzenbauer M, Hafner E, Schuchter K, Philipp K. First-trimester placental volume as a marker for chromosomal anomalies: preliminary results from an unselected population. Ultrasound Obstet Gynecol 2002; 19 (03) 240-242
- 7 Baschat AA, Harman CR. Antenatal assessment of the growth restricted fetus. Curr Opin Obstet Gynecol 2001; 13 (02) 161-168
- 8 Wolf H, Oosting H, Treffers PE. A longitudinal study of the relationship between placental and fetal growth as measured by ultrasonography. Am J Obstet Gynecol 1989; 161 (05) 1140-1145
- 9 Hayslett JP. Functional adaptation to reduction in renal mass. Physiol Rev 1979; 59 (01) 137-164
- 10 Azpurua H, Funai EF, Coraluzzi LM. , et al. Determination of placental weight using two-dimensional sonography and volumetric mathematic modeling. Am J Perinatol 2010; 27 (02) 151-155
- 11 Abramowicz JS, Sheiner E. In utero imaging of the placenta: importance for diseases of pregnancy. Placenta 2007; 28 (Suppl A): S14-S22
- 12 Gowland P. Placental MRI. Semin Fetal Neonatal Med 2005; 10 (05) 485-490
- 13 Kubik-Huch RA, Wildermuth S, Cettuzzi L. , et al. Fetus and uteroplacental unit: fast MR imaging with three-dimensional reconstruction and volumetry--feasibility study. Radiology 2001; 219 (02) 567-573
- 14 Burton GJ, Woods AW, Jauniaux E, Kingdom JC. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009; 30 (06) 473-482
- 15 Duncan KR, Sahota DS, Gowland PA. , et al. Multilevel modeling of fetal and placental growth using echo-planar magnetic resonance imaging. J Soc Gynecol Investig 2001; 8 (05) 285-290